Get the Stockscreener App
98.80
0.38%
0.37
After Hours:
98.45
-0.35
-0.35%
Spdr Biotech Etf stock is traded at $98.80, with a volume of 6.73M.
It is up +0.38% in the last 24 hours and down -2.43% over the past month.
See More
Previous Close:
$98.43
Open:
$98.1
24h Volume:
6.73M
Relative Volume:
0.89
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.39%
1M Performance:
-2.43%
6M Performance:
+4.12%
1Y Performance:
+35.31%
1-Day Range:
$97.77
$99.65
1-Week Range:
$97.42
$99.65
52-Week Range:
$63.80
$103.52
Spdr Biotech Etf Stock (XBI) Company Profile
Name
Spdr Biotech Etf
Sector
Industry
Phone
-
Address
-
Spdr Biotech Etf Stock (XBI) Latest News
6 Best Health Care ETFs to Buy Now | Investing - U.S News & World Report Money
SPDR Bloomberg Short Term High Yield Bond ETF (NYSEARCA:SJNK) Reaches New 1-Year High at $25.74 - Defense World
Biotech IPOs return as sector recovers (NYSEARCA:XBI) - Seeking Alpha
Where are the Opportunities in (XBI) - Stock Traders Daily
(09/26/24) BCYC: A Promising Play in the Biotech Sector - Moneyshow.com
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now - MSN
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now - MarketBeat
Gilead Sciences Inc (GILD-Q) QuotePress Release - The Globe and Mail
XBI Is Breaking Out And Likely To Outperform In The Near Term (Technical Analysis) - Seeking Alpha
Objective long/short (XBI) Report - Stock Traders Daily
Why Biotech ETFs Are Beating the Market - TradingView
Why Biotech ETFs Are Beating the Market - Yahoo Finance
Biotech Stocks Look Ready to Rally - Barron's
Biotech stocks poised for a comeback as interest rates fall - Finance News Network
Biotech stocks poised for a comeback as interest rates fall - ShareCafe
Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue. - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
7 Best-Performing Biotech ETFs for August 2024 - NerdWallet
3 Biotech ETFs for a Diversified Portfolio - Inkl
IBB: 3 Biotech ETFs for a Diversified Portfolio - StockNews.com
2 Biotech Stocks to Buy Hand Over Fist in August - MSN
2 Biotech Stocks to Buy Hand Over Fist in August - AOL
Mather Group LLC. Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
(XBI) Trading Report - Stock Traders Daily
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Zacks Investment Research
2 Biotech Stocks Making Moves Today - Schaeffers Research
Form 424B2 BofA Finance LLC - StreetInsider.com
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
3 Biotech Names With Potential Catalysts By Year End - Seeking Alpha
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. - sharewise
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. - Yahoo Finance
Osaic Holdings Inc. Acquires 179 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech ETF (XBI) rallied from the blue box hitting target - FXStreet
TSX Global Mining Index (TXGM) QuotePress Release - The Globe and Mail
Biotech ETF (XBI) Rallied from the Blue Box Hitting Target - Barchart
TSX 60 ESG Index (TSXE) QuotePress Release - The Globe and Mail
Kingsview Wealth Management LLC Purchases 127 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
S&P 500 VIX (VIJ20) Quote - The Globe and Mail
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Banco Santander S.A. - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Avantax Advisory Services Inc. - Defense World
Avantax Advisory Services Inc. Grows Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - American Banking and Market News
Biotech Stocks Near Massive Breakout - Investopedia
Trading (XBI) With Integrated Risk Controls - Stock Traders Daily
3 Biotech Stocks You Should Know About - Schaeffers Research
A new ETF will allow investors to cash in on the Ozempic-fueled weight loss craze that's swept markets this year - Yahoo Lifestyle UK
(07/16/24) XBI: Biotech Break Out Bodes Well for this Lagging Sector - Moneyshow.com
1 Biotech Stock to Buy Tooth and Nail and 1 to AvoidTHE BHARAT EXPRESS NEWS - The Bharat Express News
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid - MSN
3 Charts That Suggest Biotech Stocks Are Headed Higher - Investopedia
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid - Nasdaq
Spdr Biotech Etf Stock (XBI) Financials Data
There is no financial data for Spdr Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.36%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):